UC Berkeley pioneers immunotherapy

by / Thursday, 19 January 2017 / Published in news

UC Berkeley’s Immunotherapeutics and Vaccine Research Institute is changing the way we think about cancer and infectious diseases. It turns out that these two have a lot in common, and IVRI is utilizing discoveries in both fields to create strides in treatment.

The current issue of the journal Science Immunology features Russell Vance, Daniel Portnoy, Michael Eichberg, and David Raulet advocating for this research approach. Written piece can be found here.

Read the full story at UC Berkeley News Center.

TOP UA-36873340-1